Accessibility setting


Select language

Skip to secondary menu

Skip to content

Jehovah’s Witnesses


Medicine and Surgery

Management and Optimization of Hemostasis

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.

Grainger JD, Locatelli F, Chotsampancharoen T, Donyush E, Pongtanakul B, Komvilaisak P, Sosothikul D, Drelichman G, Sirachainan N, Holzhauer S, Lebedev V, Lemons R, Pospisilova D, Ramenghi U, Bussel JB, Bakshi KK, Iyengar M, Chan GW, Chagin KD, Theodore D

Source‎: Lancet 2015;386(10004):1649-58.

Indexed‎: PubMed 26231455

DOI‎: 10.1016/S0140-6736(15)61107-2.

Strategic and operational aspects of a transfusion-free neonatal arterial switch operation.

Schweiger M, Dave H, Kelly J, Hübler M.

Source‎: Interact Cardiovasc Thorac Surg 2013;16(6):890-1.

Indexed‎: PubMed 23460601

DOI‎: 10.1093/icvts/ivt010

Endoscopic technique for sagittal synostosis.

Jimenez DF, Barone CM.

Source‎: Childs Nerv Syst 2012;28(9):1333-9.

Indexed‎: PubMed 22872245

DOI‎: 10.1007/s00381-012-1768-y

Antifibrinolytic agents reduce blood loss during pediatric vertebral column resection procedures.

Newton PO, Bastrom TP, Emans JB, Shah SA, Shufflebarger HL, Sponseller PD, Sucato DJ, Lenke LG.

Source‎: Spine (Phila Pa 1976) 2012;37(23):E1459-63.

Indexed‎: PubMed 22872217

DOI‎: 10.1097/BRS.0b013e31826c9fe4

Does the intraoperative tranexamic acid decrease operative blood loss during posterior spinal fusion for treatment of adolescent idiopathic scoliosis?

Yagi M, Hasegawa J, Nagoshi N, Iizuka S, Kaneko S, Fukuda K, Takemitsu M, Shioda M, Machida M.

Source‎: Spine (Phila Pa 1976) 2012;37(21):E1336-42.

Indexed‎: PubMed 22772572

DOI‎: 10.1097/BRS.0b013e318266b6e5

Management of dilutional coagulopathy during pediatric major surgery.

Haas T, Mauch J, Weiss M, Schmugge M.

Source‎: Transfus Med Hemother 2012;39(2):114-9.

Indexed‎: PubMed 22670129

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.

Guzzetta NA, Russell IA, Williams GD.

Source‎: Anesth Analg 2012;115(2):364-78.

Indexed‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Source‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Indexed‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

A randomized control trial to verify the efficacy of pre-operative intravenous tranexamic acid in the control of tonsillectomy bleeding.

George A, Kumar R, Kumar S, Shetty S.

Source‎: Indian J Otolaryngol Head Neck Surg 2011;63(1):20-6.

Indexed‎: PubMed 22319712

DOI‎: 10.1007/s12070-010-0095-4

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Source‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Indexed‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency.

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Source‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indexed‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

Use of tranexamic acid as a rescue measure to achieve hemostasis after massive blood loss in a pediatric neurosurgical patient.

Bharath K, Bhagat H, Mohindra S.

Source‎: J Neurosurg Anesthesiol 2011;23(4):376-7.

Indexed‎: PubMed 21876453

DOI‎: 10.1097/ANA.0b013e31822c804f

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Source‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Indexed‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial.

Goobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF.

Source‎: Anesthesiology 2011;114(4):862-871.

Indexed‎: PubMed 21364458

DOI‎: 10.1097/ALN.0b013e318210fd8f

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience.

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Source‎: Indian J Pediatr 2011;78(8):961-8.

Indexed‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.